Search Within

Advanced Practice Providers

  1. "2021"
Formats
  1. Journal Article (44)
  2. Meeting Abstract (36)
  3. Review (8)
  4. Research Letter (7)
  5. Miscellaneous (3)
  6. Editorial (2)
  7. Book Section (1)
Groups
  1. Nursing (80)
  2. Department of Medicine (57)
  3. Survivorship Research (45)
  4. Center for Hematologic Malignancies (36)
  5. Hematologic Malignancies, Division of (35)
  6. Epidemiology and Biostatistics (32)

More Groups

People
  1. Ahmet Dogan (9)
  2. Andrew Zelenetz (9)
  3. Gunjan Shah (9)
  4. Maria Palomba (9)
  5. Ariela Noy (8)
  6. Miguel-Angel Perales (8)

More People

Years
  1. 2021 (101)
Publications
  1. Blood (11)
  2. Journal of Clinical Oncology (7)
  3. Clinical Journal of Oncology Nursing (5)
  4. Oncology Nursing Forum (5)
  5. Hematological Oncology (3)
  6. JCO Oncology Practice (3)

More Publications

Publishers
  1. American Society of Hematology (13)
  2. American Society of Clinical Oncology (12)
  3. Oncology Nursing Society (ONS) (10)
  4. Elsevier Inc. (8)
  5. Oxford University Press (7)
  6. Nature Publishing Group (5)

More Publishers

Results (101)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Mast cell proliferation in the cerebrospinal fluid after intraventricular administration of anti-B7H3 immunotherapy
    Journal Article

    Kramer, K.; Donzelli, M. A.; Pessin, M. S.
    Cancer Immunology, Immunotherapy (2021)

    Fulltext@MSK | Save
  • Is intravitreal topotecan toxic to retinal function?
    Journal Article

    Nadelmann, J.; Francis, J. H.; Brodie, S. E.; Muca, E.; Abramson, D. H.
    British Journal of Ophthalmology (2021)

    Fulltext@MSK | Save
  • Treating alpelisib-Induced hyperglycemia with very low carbohydrate diets and sodium-glucose co-transporter 2 inhibitors: A case series
    Journal Article

    Blow, T.; Hyde, P. N.; Falcone, J. N.; Neinstein, A.; Vasan, N.; Chitkara, R.; Hurd, M. A.; Sardesai, S.; Lustberg, M. B.; Flory, J. H.; more...
    Integrative Cancer Therapies (2021)

    Fulltext@MSK | Save
  • A phase II trial of reduced dose brentuximab vedotin for cutaneous T‐cell lymphomas
    Meeting Abstract

    Khan, N.; Noor, S.; Geller, S.; Khodadoust, M. S.; Kheterpal, M.; Hancock, H.; Davey, T.; Ryu, S.; Perez, L.; Lares, A.; more...
    Hematological Oncology (2021)

    Fulltext@MSK | Save
  • The combination of duvelisib and romidepsin (DR) is highly active against relapsed/refractory peripheral T‐cell lymphoma with low rates of transaminitis: Final results
    Meeting Abstract

    Horwitz, S. M.; Moskowitz, A. J.; Mehta‐Shah, N.; Jacobsen, E. D.; Khodadoust, M. S.; Ganesan, N.; Drill, E.; Hancock, H.; Davey, T.; Myskowski, P.; more...
    Hematological Oncology (2021)

    Fulltext@MSK | Save
  • Phase I study of bendamustine, rituximab, ibrutinib, and venetoclax in relapsed, refractory mantle cell lymphoma
    Meeting Abstract

    Kumar, A.; Batlevi, C.; Drullinsky, P.; Grieve, C.; Laraque, L.; Joseph, A.; Mahajan, N.; Matasar, M.; Straus, D.; Zelenetz, A.; more...
    Hematological Oncology (2021)

    Fulltext@MSK | Save
  • Four cycles of etoposide plus cisplatin for patients with good-risk advanced germ cell tumors
    Journal Article

    Funt, S. A.; McHugh, D. J.; Tsai, S.; Knezevic, A.; O'Donnell, D.; Patil, S.; Silber, D.; Bromberg, M.; Carousso, M.; Reuter, V. E.; more...
    The Oncologist (2021)

    Fulltext@MSK | Save
  • Productivity measures: Empowering oncology nurse practitioners to understand and demonstrate value in practice
    Review

    McGuire, M.; Olivo, A.; Yackzan, S.
    Clinical Journal of Oncology Nursing (2021)

    Fulltext@MSK | Save
  • Cardiac toxicity: Using angiotensin-converting enzyme inhibitors to prevent anthracycline-induced left ventricular dysfunction and cardiomyopathy
    Journal Article

    Kobza, C. A.
    Clinical Journal of Oncology Nursing (2021)

    Fulltext@MSK | Save
  • The glitter of the simple
    Miscellaneous

    Fry, A.
    Annals of Internal Medicine (2021)

    Fulltext@MSK | Save